Clinical Trials Directory

Trials / Completed

CompletedNCT05836532

Long Term Results of Surgical and Percutaneous Double Orefices Mitral Repair in Patient With p2 Prolapse Causing Degenerative Mitral Regurgitation

Status
Completed
Phase
Study type
Observational
Enrollment
110 (actual)
Sponsor
Michele De Bonis · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Mitral regurgitation is a pathology affecting the left atrioventricular valve that causes a volumetric and pressure overload in the left chambers due to the loss of unidirectionality normally guaranteed by the cardiac valve system. The gold standard for severe mitral regurgitation is currently mitral valve plastic surgery. Edge to edge, on the other hand, allows shorter CEC and aortic clamping times and does not require significant surgical experience in the field of mitral valve repair, therefore edge to edge could be an excellent strategy in patients suffering from mitral regurgitation caused by P2 prolapse when quadrangular resection cannot be performed. The main objective of the present study is to examine the medium to long-term outcomes (in terms of survival and plastic outcomes) of patients undergoing central edge-to-edge to treat posterior flap pathology (P2).

Conditions

Interventions

TypeNameDescription
PROCEDURECentral edge-to-edgeSuture of free margins of the mitral leaflets in central position to restore coaptation

Timeline

Start date
2019-10-05
Primary completion
2019-10-15
Completion
2019-10-15
First posted
2023-05-01
Last updated
2023-05-01

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05836532. Inclusion in this directory is not an endorsement.